Deep Lung Deposition

Deep Lung Deposition is a pharmacokinetic process denoting the deposition of inhaled aerosolized drug particles specifically within the alveolar and small airway regions of the lungs, distinguished from upper airway deposition by particle size, inhalation dynamics, and targeted therapeutic intent.

68

Publications

2.8K

Citations

327

Authors

128

Institutions

Publications per year

2017–2026

29

Authors

327

  1. DR
    David R. Hemenway

    University of Vermont, United States

    3 publications · 48 citations

    3

    h-index

  2. RV
    Rita Vanbever

    UCLouvain, Belgium

    3 publications · 156 citations

    3

    h-index

  3. LY
    Leslie Y. Yeo

    RMIT University, Australia

    3 publications · 129 citations

    3

    h-index

  4. EA
    Elsayeda-Zeinab A. Abdelfattah

    Alexandria University, Egypt

    3 publications · 201 citations

    3

    h-index

  5. MW
    Maged W. Helmy

    Damanhour University, Egypt

    3 publications · 201 citations

    3

    h-index

1–5 of 327

Venues

  1. Health Physics

    3 publications · 58 citations

    3

    h-index

  2. International Journal of Pharmaceutics

    3 publications · 96 citations

    3

    h-index

  3. 3

    h-index

  4. Pharmaceutics

    3 publications · 75 citations

    3

    h-index

  5. Journal of Aerosol Medicine

    2 publications · 67 citations

    2

    h-index

1–5